Next Article in Journal
The Role of Daily Activity in Risk and Survival Outcomes for Chronic Lymphocytic Leukemia Patients: Baseline Insights from the ADRENALINE Pilot Study
Previous Article in Journal
Lymphatic Spread of Non-Small-Cell Lung Cancer: Mechanisms, Patterns, Staging, and Diagnosis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Ramos Peñafiel et al. Effect of ABCB1 Expression on Measurable Residual Disease in Adult Patients with Acute Lymphoblastic Leukemia. Lymphatics 2025, 3, 6

by
Christian Omar Ramos Peñafiel
1,
Adolfo Martínez Tovar
2,
Daniela Pérez Sámano
1,
Rafael Cerón Maldonado
2,
Adán Germán Gallardo Rodríguez
3,
Carlos Martínez Murillo
1 and
Irma Olarte Carrillo
2,*
1
Hematology Department, Hospital General de México “Dr. Eduardo Liceaga”, Mexico City P.C. 06720, Mexico
2
Molecular Biology Laboratory, Hospital General de México “Dr. Eduardo Liceaga”, Mexico City P.C. 06720, Mexico
3
Hematology Research Department, Hospital General de México “Dr. Eduardo Liceaga”, Mexico City P.C. 06720, Mexico
*
Author to whom correspondence should be addressed.
Lymphatics 2025, 3(4), 44; https://doi.org/10.3390/lymphatics3040044
Submission received: 12 November 2025 / Accepted: 17 November 2025 / Published: 8 December 2025
In the original publication [1], the Informed Consent Statement was incorrectly stated as “Not applicable”. Since the study involved human participants, a correction has been made to update and clarify the Informed Consent Statement. The updated declaration has now been added in the Informed Consent Statement to explicitly state that informed consent was obtained from all participants involved in the study. This correction was approved by the Academic Editor. The original publication has also been updated.
The added statement is as follows:
Informed consent was obtained from the patient involved in the article.

Reference

  1. Ramos Peñafiel, C.O.; Martínez Tovar, A.; Pérez Sámano, D.; Cerón Maldonado, R.; Gallardo Rodríguez, A.G.; Martínez Murillo, C.; Olarte Carrillo, I. Effect of ABCB1 Expression on Measurable Residual Disease in Adult Patients with Acute Lymphoblastic Leukemia. Lymphatics 2025, 3, 6. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ramos Peñafiel, C.O.; Martínez Tovar, A.; Pérez Sámano, D.; Cerón Maldonado, R.; Gallardo Rodríguez, A.G.; Martínez Murillo, C.; Olarte Carrillo, I. Correction: Ramos Peñafiel et al. Effect of ABCB1 Expression on Measurable Residual Disease in Adult Patients with Acute Lymphoblastic Leukemia. Lymphatics 2025, 3, 6. Lymphatics 2025, 3, 44. https://doi.org/10.3390/lymphatics3040044

AMA Style

Ramos Peñafiel CO, Martínez Tovar A, Pérez Sámano D, Cerón Maldonado R, Gallardo Rodríguez AG, Martínez Murillo C, Olarte Carrillo I. Correction: Ramos Peñafiel et al. Effect of ABCB1 Expression on Measurable Residual Disease in Adult Patients with Acute Lymphoblastic Leukemia. Lymphatics 2025, 3, 6. Lymphatics. 2025; 3(4):44. https://doi.org/10.3390/lymphatics3040044

Chicago/Turabian Style

Ramos Peñafiel, Christian Omar, Adolfo Martínez Tovar, Daniela Pérez Sámano, Rafael Cerón Maldonado, Adán Germán Gallardo Rodríguez, Carlos Martínez Murillo, and Irma Olarte Carrillo. 2025. "Correction: Ramos Peñafiel et al. Effect of ABCB1 Expression on Measurable Residual Disease in Adult Patients with Acute Lymphoblastic Leukemia. Lymphatics 2025, 3, 6" Lymphatics 3, no. 4: 44. https://doi.org/10.3390/lymphatics3040044

APA Style

Ramos Peñafiel, C. O., Martínez Tovar, A., Pérez Sámano, D., Cerón Maldonado, R., Gallardo Rodríguez, A. G., Martínez Murillo, C., & Olarte Carrillo, I. (2025). Correction: Ramos Peñafiel et al. Effect of ABCB1 Expression on Measurable Residual Disease in Adult Patients with Acute Lymphoblastic Leukemia. Lymphatics 2025, 3, 6. Lymphatics, 3(4), 44. https://doi.org/10.3390/lymphatics3040044

Article Metrics

Back to TopTop